Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Committee advances substitute to require coverage for IVIG in certain pediatric neuropsychiatric disorders with prior authorization

2574156 · March 11, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

A committee substitute for Senate Bill 297 that would require coverage for IVIG therapy in certain pediatric neuropsychiatric disorders after prior authorization was reported to the full Senate with a recommendation that it pass and a first referral to the Finance Committee.

A committee substitute for Senate Bill 297 that would require coverage for intravenous immunoglobulin (IVIG) therapy for specified pediatric neuropsychiatric disorders was reported to the full Senate with the recommendation that it pass and a first referral to the Finance Committee.

The committee’s counsel told members the bill "requires coverage for intravenous immunoglobulin therapy for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric…

Already have an account? Log in

Subscribe to keep reading

Unlock the rest of this article — and every article on Citizen Portal.

  • Unlimited articles
  • AI-powered breakdowns of topics, speakers, decisions, and budgets
  • Instant alerts when your location has a new meeting
  • Follow topics and more locations
  • 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans